Results 1 to 10 of about 30,582 (303)

Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis

Orphanet Journal of Rare Diseases, 2021
Background The effects of thymectomy on late-onset non-thymomatous myasthenia gravis (NTMG) remain controversial. The objective of this study was to conduct a systematic review in order to answer two questions pertinent to late-onset NTMG: (1) do ...
Jinwei Zhang, Yuan Chen, Hui Zhang, Zhaoyu Yang, Peng Zhang   +4 more
doaj   +2 more sources

Survival and autoimmune risks post-thymectomy [PDF]

Frontiers in Immunology
Background and objectivesRecent studies have raised concerns about thymectomy's deleterious effects. However, this conclusion was not exclusive to patients with myasthenia gravis (MG). The objective of this study was to test this hypothesis in thymectomy
Irina Tsirkin, Mohamed Khateb, Dvir Aran, Dvir Aran, Amit Kaz, Shahar Shelly, Shahar Shelly, Shahar Shelly   +7 more
doaj   +2 more sources

Successful Management of Post-Thymectomy Pure Red Cell Aplasia with Rituximab: A Case Report [PDF]

Case Reports in Oncology
Background: Pure red cell aplasia (PRCA) is a rare cause of anemia characterized by decreased red blood cell production, often associated with thymomas.
Mohammed Abdulgayoom, Ibrahim Ganwo, Fateen Ata, Haval Surchi, Ussama Al-Homsi, Honar Cherif   +5 more
doaj   +2 more sources

The neurological outcome in the patients with myasthenia gravis who underwent thymectomy via sternotomy and video-assisted thoracoscopic surgery (VATS) [PDF]

Vojnosanitetski Pregled, 2021
Background/Aim. Thymectomy is accepted in the surgical treatment of the patients with myasthenia gravis (MG). Earlier thymectomy via sternotomy has recently been replaced by video-assisted thoracoscopic surgery (VATS), which is less invasive.
Martić Vesna, Marić Nebojša, Cvijanović Vlado   +2 more
doaj   +1 more source

Robotic thymectomy: a review of techniques and results

Polish Journal of Thoracic and Cardiovascular Surgery, 2023
Thymectomy is a well-established therapeutic option in the multidisciplinary treatment of nonthymomatous myasthenia gravis (MG) and in thymoma treatment.
Danilo Coco, Silvana Leanza
doaj   +1 more source

Case Series: Clinical Impact of Plasmapheresis and Thymectomy on Early-Onset Myasthenia Gravis

Case Reports in Neurology, 2021
Thymectomy is a common procedure performed in cases of myasthenia gravis (MG) with a thymoma or general MG that does not improve with medical therapy. This procedure is usually preceded by plasmapheresis to prevent the occurrence of myasthenic crisis and
Yusak M.T. Siahaan, Retno Jayantri Ketaren, Aristo Rinaldi Pangestu, Vinson Hartoyo   +3 more
doaj   +1 more source

Risk Benefit Analysis of Routine Thymectomy for Differentiated Thyroid Cancers: A Systematic Review

The Surgery Journal, 2021
Background Central compartment lymph node dissection (CLND) is a part of the surgical management of differentiated thyroid cancer (DTC). Therapeutic CLND is done to address clinically significant central compartment nodes in patients with DTC, while ...
Pallvi Kaul, Priyanka Kaul, Dharma Ram Poonia, Ashish Jakhetiya, Vipin Arora, Pankaj Kumar Garg   +5 more
doaj   +1 more source

The dilemma of thymectomy in myasthenia gravis

Apollo Medicine, 2020
Myasthenia gravis (MG) is an autoimmune disease that affects the neuromuscular junction causing fluctuating weakness of skeletal muscles. It is considered a rare disease with an estimated prevalence of 7.77/100,000.
Pushpendra Nath Renjen, Dinesh Mohan Chaudhari, Anjali Mishra   +2 more
doaj   +1 more source

Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort

Thoracic Cancer, 2023
Background Myasthenia gravis (MG) patients are reported to have a high risk of other autoimmune diseases (ADs), and thymectomy may increase the risk further.
Wenxin Tian, Jing He, Hanbo Yu, Yaoguang Sun, Qingjun Wu, Peng Jiao, Chao Ma, Chuan Huang, Donghang Li, Hongfeng Tong   +9 more
doaj   +1 more source

Thymoma‐associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma

Thoracic Cancer, 2021
Background Thymoma‐associated myasthenia gravis (TAMG) is one of the subtypes of myasthenia gravis with autoantibodies against the acetylcholine receptor (AChR‐Ab).
Anna De Rosa, Marco Fornili, Michelangelo Maestri Tassoni, Melania Guida, Laura Baglietto, Loredana Petrucci, Antonio Chella, Franca Melfi, Marco Lucchi, Roberta Ricciardi   +9 more
doaj   +1 more source